PMID: 11933574Apr 6, 2002Paper

Acute leukemia

Clinics in Laboratory Medicine
Harold R SchumacherFermina Mazzella

Abstract

This article provides a review of the acute leukemias with updated basic and practical information. The main emphasis is on techniques used to arrive at the correct diagnosis. Although morphology and cytochemistry were the mainstays of diagnosis in the past, new developments in immunophenotyping, cytogenetics, molecular biology, and in vitro assays have improved the understanding of this disease dramatically and enable the identification of new entities with distinct clinicobiologic features.

References

Apr 11, 1992·American Journal of Epidemiology·L M BrownJ F Fraumeni
Jul 1, 1991·British Journal of Haematology·J M BennettC Sultan
Nov 22, 1991·Science·R A Weinberg
Aug 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J BorowitzW M Crist
Nov 1, 1987·Cancer Genetics and Cytogenetics·R BergerF Sigaux
Jul 1, 1984·British Journal of Haematology·S A StassG V Dahl
Feb 1, 1996·Annals of Hematology·H D Friedman, S A Landaw
Jun 1, 1996·Cancer Genetics and Cytogenetics·M HorstmannO A Haas
Jan 14, 1998·American Journal of Clinical Pathology·M C CoxS Amadori
Aug 28, 1998·Leukemia & Lymphoma·N AsouK Takatsuki
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L HarrisC D Bloomfield
Jan 11, 2000·Archives of Pathology & Laboratory Medicine·J FaberM Albitar
Mar 25, 2000·Cancer Genetics and Cytogenetics·K S ReddyT L Yu
Jun 10, 2000·British Journal of Haematology·C H Pui, M V Relling
Apr 24, 1958·Annals of the New York Academy of Sciences·A L WALPOLE

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.